Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07373288

HOXB7 and Linked Tissue and Blood Biomarkers in the Lungs of Patients With Pulmonary Fibrosis

Status
Recruiting
Phase
Study type
Observational
Enrollment
80 (estimated)
Sponsor
University of Modena and Reggio Emilia · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

This pilot, multicenter, interventional study investigates the expression of HOXB7 and its associated molecular pathway in lung tissue and blood-derived exosomes from patients with pulmonary fibrosis (PF), including idiopathic pulmonary fibrosis (IPF). Using RNA sequencing (RNA-Seq) and proteomic analysis via mass spectrometry (MS), the study aims to identify tissue and circulating biomarkers associated with fibrosis progression. The study compares different biopsy techniques (surgical vs. transbronchial cryobiopsy) and also includes a control group of patients undergoing lung resection for non-fibrotic conditions.

Conditions

Interventions

TypeNameDescription
PROCEDUREBiopsyThis is a non-therapeutic, observational sampling study. Procedures include: Lung tissue sampling via: Surgical biopsy Transbronchial cryobiopsy Explanted lungs from transplant patients Blood sampling for exosome analysis

Timeline

Start date
2023-07-01
Primary completion
2027-07-01
Completion
2030-07-01
First posted
2026-01-28
Last updated
2026-02-04

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT07373288. Inclusion in this directory is not an endorsement.